The following is the third installment of the excerpted panel discussion, “Future Visions: Are We Heading to Heaven, Hell or Purgatory?,” that Saama Technologies’ Chief Strategy Officer Sagar Anisingaraju participated in on October 28 at MAGI’s Clinical Research Conference – 2019 West, in Las Vegas. The discussion was moderated by Jonathan Zung, Ph.D., member of Saama’s Clinical Board of Advisors and EVP, WCG. 

——————————

Jonathan Zung: Will AI allow sponsors to dramatically reduce the number of subjects in a trial?


Read More...